Design, identification, and sensitivity analysis for patient preference trials
DOI10.1080/01621459.2019.1585248zbMATH Open1428.62472OpenAlexW2559836499WikidataQ128310812 ScholiaQ128310812MaRDI QIDQ5208058FDOQ5208058
Authors: Dean Knox, Teppei Yamamoto, Matthew A. Baum, Adam J. Berinsky 
Publication date: 15 January 2020
Published in: Journal of the American Statistical Association (Search for Journal in Brave)
Full work available at URL: https://hdl.handle.net/1721.1/132193
Recommendations
- Causal Inference in Hybrid Intervention Trials Involving Treatment Choice
- Clinician preferences and the estimation of causal treatment differences. (With comments)
- Polydesigns and Causal Inference
- Using explicit clinician preferences in nonrandomized study designs
- Individual treatment effects in randomized trials with binary outcomes.
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05)
Cites Work
- Principal stratification in causal inference
- Observational studies.
- Comment on J. Neyman and causal inference in experiments and observational studies: On the application of probability theory to agricultural experiments. Essay on principles. Section 9 [Ann. Agric. Sci. 10 (1923), 1--51]
- Assessing the effect of an influenza vaccine in an encouragement design
- Bounds on Treatment Effects From Studies With Imperfect Compliance
- Nonparametric Analysis of Randomized Experiments with Missing Covariate and Outcome Data
- Causal Inference in Hybrid Intervention Trials Involving Treatment Choice
Cited In (5)
- Causal Inference in Hybrid Intervention Trials Involving Treatment Choice
- Clinician preferences and the estimation of causal treatment differences. (With comments)
- Using explicit clinician preferences in nonrandomized study designs
- Inference without randomization or ignorability: a stability-controlled quasi-experiment on the prevention of tuberculosis
- Representation and Extrapolation: Evidence from Clinical Trials
This page was built for publication: Design, identification, and sensitivity analysis for patient preference trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5208058)
